story of the week
Sacituzumab Govitecan Improves Survival in Metastatic TNBC
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
The New England Journal of Medicine
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Sacituzumab Govitecan in Metastatic Triple-Negative Breast Cancer
N. Engl. J. Med 2021 Apr 22;384(16)1529-1541, A Bardia, SA Hurvitz, SM Tolaney, D Loirat, K Punie, M Oliveira, A Brufsky, SD Sardesai, K Kalinsky, AB Zelnak, R Weaver, T Traina, F Dalenc, P Aftimos, F Lynce, S Diab, J Cortés, J O'Shaughnessy, V Diéras, C Ferrario, P Schmid, LA Carey, L Gianni, MJ Piccart, S Loibl, DM Goldenberg, Q Hong, MS Olivo, LM Itri, HS Rugo,From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.